GreyMatters

Educational articles, BetterBrain resources, latest in brain health, and news about us. Written for you, with expertise (and love).

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
June 16, 2026
5 mins

Grey Matters: A one-time injection that could lower LDL cholesterol for life

The therapy, called VERVE-102, targets a gene called PCSK9. PCSK9 is a protein that reduces your liver’s ability to clear LDL cholesterol from...

The Science: Editing One Gene to Lower Cholesterol

The therapy, called VERVE-102, targets a gene called PCSK9.

PCSK9 is a protein that reduces your liver’s ability to clear LDL cholesterol from your blood. The more PCSK9 activity you have, the fewer LDL "receptors" your liver keeps available to pull LDL particles out of circulation. Some people are born with naturally low-functioning PCSK9 genes, and they tend to have markedly lower LDL across their entire lives and substantially lower rates of heart disease, with no apparent downside. In other words, turning down PCSK9 is a known protective pattern scientists have studied for two decades. We already have approved PCSK9-lowering drugs, but they require ongoing injections.

What’s new is the delivery. VERVE-102 uses base editing, a precise form of gene editing, to make a single change to the PCSK9 gene in liver cells after one infusion. The goal is to do once, durably, what current drugs do repeatedly.

In the Heart-2 trial, the early results were striking. A single dose lowered LDL cholesterol by an average of around 50%, and by as much as roughly 69% at the higher doses, with reductions holding for up to 18 months. The therapy was well tolerated, with no treatment-related serious adverse events reported.

The Bottom Line: A one-time gene editing infusion produced large, durable reductions in LDL cholesterol in an early trial, by mimicking a protective genetic pattern that already exists in nature.

The honest caveats:

The headline is easy to over-read, so here’s the careful version.

It’s a phase 1b trial. That’s an early stage focused mainly on safety and initial signals, in a small number of participants. It has not yet been shown to prevent heart attacks, strokes, or cognitive decline.

It’s a specific patient group. The trial enrolled people with an inherited form of very high cholesterol or early coronary artery disease, who need aggressive LDL lowering. These are not general-population results.

Gene editing is genuinely new. The PCSK9 mechanism is exceptionally well understood, which is reassuring. But making a permanent edit to a gene is a young field, and the long-term safety story takes years to write. As a result, this drug is likely to be approved initially for very high-risk individuals such as those with familial hypercholesterolemia. It could be prescribed off-label, but it is likely to be very expensive.

It’s years away. The next step is a larger phase 2 trial. Broad availability is well down the road.

Why this is a brain-health story, not just a heart story

At BetterBrain, we look at the whole body, because your brain doesn’t exist in isolation from it. And few things connect the two as directly as lipids.

Start with ApoB. You’ve probably heard of LDL cholesterol. ApoB is the more precise number underneath it. Every LDL particle carries exactly one ApoB protein, so LDL-C tells you the amount of cholesterol in LDL particles, while ApoB tells you the number of particles actually driving damage in your artery walls. When the two disagree, ApoB is the better predictor of risk. Lowering PCSK9, whether through these new therapies or the drugs we already have, lowers both.

Now connect it to the brain. The blood vessels that feed your brain are subject to the same lipid-driven damage as the ones feeding your heart, and that vascular damage is one of the major pathways of cognitive decline. Protecting your lipids over a lifetime is protecting your brain. This is especially true for people who tend to run higher LDL, including APOE4 carriers, which is one reason lipid management is a core part of what we do at BetterBrain.

And here’s the bigger picture.Between therapies like this one and the medications we already have, the tools for managing cardiovascular disease are getting remarkably good, and they’re only going to get better. But adding years to your life is only valuable if your brain is still working well for those years. That’s the conversation most people aren’t having yet, and it’s the one that matters most to us at BetterBrain.

What this means for you, right now

You don’t have to wait for a therapy that’s years away. The target itself, your lipid health, is something you can measure and move today.

Get your ApoB tested, not just standard cholesterol. ApoB counts the particles actually driving damage, and it’s one of the most informative markers for both heart and brain health.

Think of lipids as a lifelong number. The PCSK9 story shows that it’s the decades of cumulative exposure that drive risk, which means small, steady improvements compound in your favor. Starting earlier is always worth more than starting perfectly.

Use the levers you already have. Diet, regular movement, and, where your physician recommends them, proven medications all lower lipids today.

Your BetterBrain coach can pull your ApoB and your full lipid picture into one clear plan, so that whatever arrives in five or ten years, you’ve protected the decades in between.

June 9, 2026
6 mins

The Glymphatic System: Why Deep Sleep Is Your Brain's Best Cleanup Tool

The Glymphatic System: Why Deep Sleep Is Your Brain's Best Cleanup Tool

Featured System: How Your Brain Takes Out the Trash

Every other tissue in your body has lymphatic vessels to carry away metabolic waste. For a long time the brain was thought to be the exception, with no obvious plumbing for the job. That changed in 2013, when researchers described what’s now called the glymphatic system: a network that uses cerebrospinal fluid to flush waste out of brain tissue, including amyloid-beta and tau, the proteins that accumulate in Alzheimer’s disease.

The finding that reshaped how we think about sleep came alongside it. Glymphatic clearance is not constant. It ramps up dramatically during deep, slow-wave sleep, when the spaces between brain cells expand and fluid can move through more freely. This is one of the clearest biological reasons that sleep is not optional maintenance. It is when a specific, measurable cleanup process actually runs.

So the existence of the system is well established. The question researchers have kept working on is mechanical: what physically moves the fluid?

What the newer research adds

A 2025 study in Cell from Maiken Nedergaard’s group (one of the labs behind the original glymphatic work) helps answer that question. In mice, the team showed that during deep sleep a small brainstem region called the locus coeruleus releases norepinephrine in slow, rhythmic waves, roughly one every fifty seconds. Each wave gently tightens and relaxes the blood vessels, and that slow oscillation appears to act like a pump, driving cerebrospinal fluid through the brain to move waste along.

It’s an elegant result because it connects three things we already knew were related (deep sleep, blood-vessel tone, and fluid clearance) into a single mechanism. It reframes deep sleep not as the brain idling, but as the brain running a coordinated pump.

Two points of rigor worth keeping straight, because they change how much weight any single study can carry:

  • This is animal research. The norepinephrine-wave mechanism has been demonstrated in mice, whose sleep biology is a strong but imperfect model for ours. It tells us how the system likely works; it is not a human clinical trial.
  • And the same study raised a careful question about sleep medication. The researchers found that zolpidem (the active ingredient in Ambien) suppressed these norepinephrine waves in mice and reduced fluid flow. That is a genuinely interesting signal, but it is a finding in animals about a mechanism, not evidence that a prescription harms people. If you take a sleep aid, this is not a reason to stop. It is a reason to make the underlying sleep quality a real conversation with your doctor.

Bottom Line: The glymphatic system and its dependence on deep sleep are well established. The newer work gives us a plausible engine for it, the slow norepinephrine rhythm of deep sleep, and a reminder that how you sleep, not just how long, is what lets the system do its job.

What this means for you

None of this requires a new gadget or supplement. It reinforces the fundamentals, and gives you a sharper reason to take them seriously.

Protect the deep-sleep window. Slow-wave sleep is concentrated in the first half of the night. A consistent wake time, morning light exposure, and a cool, dark room are the most reliable ways to protect it.

Be honest about alcohol and late meals. Both fragment the deep-sleep stages where clearance is most active. You may fall asleep fine and still lose the part of the night that matters most here.

Treat sleep as something you can measure. The same way we track a biomarker, sleep consistency and quality are worth paying attention to over time rather than guessing at.

Take loud snoring or daytime exhaustion seriously. These can signal sleep apnea, which repeatedly interrupts the deep sleep this system depends on, and it is both common and treatable. It’s worth flagging to a clinician.

Keep prescriptions in your doctor’s hands. If you use a sleep medication, bring the goal of better sleep quality to your prescriber rather than changing anything on your own.

Your BetterBrain coach can help you turn any of this into a specific, trackable Sleep Practice rather than a vague intention to "sleep better."

June 2, 2026
3 mins

Grey Matters: Stimulation, Sleep, Nutrient Supply: Tommy's 3-S Model

The first S, Stimulation, is the one that surprises people. Tommy’s argument is that the brain, like muscle, needs ongoing challenges to maintain...

Stimulation

The first S, Stimulation, is the one that surprises people. Tommy’s argument is that the brain, like muscle, needs ongoing challenges to maintain its structure. The novelty is the variable. Doing the same crossword every day is not stimulation in the sense your brain cares about. Learning a language, taking up a new instrument, taking a class on something you have no prior context for, are stimulating.

This connects to what is called cognitive reserve, the buffer your brain builds through years of varied learning. Cognitive reserve is one of the strongest predictors of who maintains function in their 70s and 80s, even in the presence of pathology like amyloid plaques.

What you can do this week: pick one thing this month that you do not already know how to do. It does not have to be heavy. A new recipe technique, a new fitness class, a new route on your morning walk that requires you to navigate. The brain treats novelty as a signal that it needs to keep adapting.

Support

The second S is the one most people know is important and still underestimate. Recovery, especially during sleep, is when the brain adapts and improves.

While you sleep, your brain runs a waste-clearance system that flushes out the proteins that build up during the day, including amyloid, the same protein that accumulates in Alzheimer’s disease. Think of it like a dishwasher that only runs at night. Skip enough nights, or get consistently shallow sleep, and the dishes pile up. Disrupted sleep is associated with elevated pTau-217, lower cognitive scores, and higher long-term dementia risk.

Tommy is direct about this in the book: there is no supplement protocol that compensates for chronically poor sleep. And the work has to start with the structure of your sleep itself, meaning how much time you actually spend in the deep and REM stages, not just how many hours you’re in bed. You can sleep eight hours and still miss most of the stages where the real restoration happens.

What you can do this week: protect a consistent wake time. The wake time matters more than the bedtime because it anchors your body’s internal clock. Pair it with morning light within 30 minutes of getting up, and you’ve done more for your sleep quality than most people manage with supplements or sleep trackers alone.

Supply

The third S is where a meaningful part of your biomarker picture lives, though it’s worth noting that sleep and stimulation have their own markers too. Your brain runs on a continuous supply of glucose, oxygen, omega-3 fatty acids, B vitamins, and a long list of micronutrients. Deficits in any of these can quietly compromise function for years before they show up as symptoms. And the flip side is equally true: when these markers are at optimal levels, they actively protect your brain, often for decades.

The first place to look is diet. What you eat every day is the primary driver of whether your brain gets what it needs, and it’s also the first lever your coach will pull when something looks off. Targeted supplementation comes second, once you know where the gaps actually are.

The biomarkers we look at first in the Blueprint panel are homocysteine, vitamin D, vitamin B12, ferritin, and folate. These are the ones most likely to flag a nutrient supply problem before you feel it. And the fix is usually targeted, not maximal. Most clients don’t need fifteen supplements. They need the right two or three, chosen based on what their labs actually show.

If you haven’t had a full brain-health panel in the past year, that’s where to start. The reason we look at the whole picture rather than a single marker is that everything is connected. Your metabolic health affects your brain. Your inflammatory markers affect your brain. Your cardiovascular health affects your brain. A nutrient gap rarely shows up in isolation, and the right intervention for you depends on seeing how all of it fits together, not just the one number that looks off.

Why all three matter together

The argument the book makes is that the components that support brain health aren’t a long list of individual variables, but an integrated network. Stimulation without sleep does not give the brain time to consolidate. Sleep without nutrient supply leaves the brain trying to do its overnight work without raw materials. Nutrient supply without stimulation gives the brain everything it needs to grow but no reason to.

This is consistent with what BetterBrain’s coaches see in practice. Clients who arrive working hard on one of the three but ignoring the others tend to plateau. The ones who address all three see the biggest shifts in biomarkers, cognitive scores, and how they actually feel.

The Bottom Line

The Stimulated Mind is the best communication of modern brain science today and is worth reading whether you are at the beginning of thinking about your brain health or several years into a protocol. The three s model is an incredible framework and working with our coaches to find the right techniques across the 12 practices will help you make sure you are improving at all three S’s. 

May 26, 2026
6 mins

hs-CRP: The Biomarker Most Likely to Flag Silent Inflammation in Brain Health

CRP or C-reactive protein is made by your liver in response to inflammation anywhere in your body. The "hs" stands for "high-sensitivity," which...

What hs-CRP measures

CRP or C-reactive protein is made by your liver in response to inflammation anywhere in your body. The "hs" stands for "high-sensitivity," which means the test can detect very low levels of CRP that the standard CRP test cannot.

Standard CRP is designed to spot acute inflammation, like an active infection or a recent injury. The values it flags are high enough to indicate something is actively wrong right now. hs-CRP is designed to spot chronic low-grade inflammation, the kind that does not feel like anything but is associated with long-term risk for cardiovascular disease, type 2 diabetes, and cognitive decline.

For brain health, the chronic low-grade version is the one we care about.

Chronic systemic inflammation is associated with neuroinflammation, the inflammatory state of the brain itself. The mechanism is not fully understood, but the body of evidence is large. People with higher long-term hs-CRP have higher rates of cognitive decline, faster brain atrophy on imaging, and elevated risk of Alzheimer’s disease.

Inflammation does not directly cause Alzheimer’s, but it appears to be one of the upstream conditions that lets the underlying pathology progress more quickly. Lowering it is one of the few interventions where the evidence is consistent across cardiovascular, metabolic, and cognitive outcomes.

What the numbers mean

  • Optimal: under 1.0 mg/L
  • Borderline: 1.0 to 3.0 mg/L
  • High: above 3.0 mg/L

Most standard labs flag a result only when it crosses 3.0 mg/L or higher. The 1.0 to 3.0 range is where a meaningful number of clients are quietly running elevated. Their primary care has waved it off as "in range." However, for brain health purposes, this is not optimal.

The biomarkers that pair with hs-CRP

A single hs-CRP value is informative but more useful with other biomarkers to understand the whole picture. The markers we look at alongside it:

Homocysteine. Elevated homocysteine is associated with both inflammation and methylation problems. If hs-CRP and homocysteine are both elevated, the inflammation is likely driven in part by nutrient gaps.

ApoB and Lp(a). Cardiovascular markers. Elevated hs-CRP plus elevated ApoB is a particularly bad combination for vascular brain health.

HbA1c and Fasting Insulin. Metabolic markers. Glycemic dysfunction drives systemic inflammation. If hs-CRP is elevated, look here next.

Ferritin. Iron storage. Elevated ferritin can indicate underlying inflammation, separate from iron status.

The picture you assemble from these markers tells you whether the inflammation is metabolic, vascular, nutrient-driven, or something else.

What you can do about it

The interventions that consistently move hs-CRP often overlap with the same levers that support long-term cognitive health: sleep, glycemic control, omega-3 status, dental health, gut health, and visceral fat reduction. Because hs-CRP can be influenced by several systems at once, the right next step is not to try everything at once. It is to identify the most likely driver in your case, based on your other markers, symptoms, habits, and what you are already doing consistently.

For BetterBrain clients with elevated hs-CRP, the coaching protocol usually starts with the highest-leverage area their panel reveals. If hs-CRP is elevated alongside high HbA1c, the first priority may be blood sugar regulation. If it is elevated alongside high homocysteine, the starting point may be methylated B-complex and a closer look at folate, B12, and B6 intake. The goal is not to guess. It is to use the panel to identify the most likely driver and prioritize the change most likely to move the needle.

The Bottom Line

hs-CRP is one of the most useful brain-health markers in routine bloodwork, and one of the most commonly missed. If you have not had a high-sensitivity version of CRP measured in the past year, it is worth checking.

If you'd like the full panel with coach interpretation, BetterBrain Blueprint covers hs-CRP alongside 50+ other markers and starts at $89 with insurance.

May 20, 2026
5 mins

Grey Matters: The four Essential Techniques our coaches keep recommending

Maggie works with clients across the metabolic-health side of our client base. The trend she keeps seeing: HbA1c and fasting insulin numbers...

Move Practice: The post meal walk

Maggie works with clients across the metabolic-health side of our client base. The trend she keeps seeing: HbA1c and fasting insulin numbers creeping into pre-diabetic ranges, often without the client realizing it. Many of them are exercising, but most of them are not walking after meals.

"Ten minutes after each meal. That is the rule I get the highest compliance on, because nobody can argue they don't have ten minutes. And it does more than people expect."

The evidence behind post meal walks is broad and the bar to entry is low. A short walk after eating blunts the post-meal glucose spike. Repeated over months, it is one of the most reliable ways we have seen to shift HbA1c, fasting insulin, and the metabolic conditions that drive midlife brain atrophy. The cost is nothing, the schedule disruption is minimal, and the long-term payoff compounds. It is essential because it works for almost everyone.

Sleep Practice: Consistent wake time and morning light

Emily works with a large share of our clients who came to BetterBrain because of family history of dementia. The trend she keeps seeing: anxious clients arriving with long supplement lists, wanting to talk about pTau-217 and APOE4, while sleeping six or fewer hours a night.

"One night of four hours isn't really the question. The question is why someone is typically sleeping four or five hours at most. Patterns matter. What we identify from the first visit and where we end up is more than one night of poor sleep. Sleep is the foundation. Exercise goals, stress management, eating, they all land once sleep patterns are optimized."

The Essential Technique Emily points to first is in our Sleep Practice: a consistent wake time paired with morning light. The reason this is essential for almost everyone is the glymphatic system. Sleep is the period during which the brain runs its only clearance system, including the clearance of amyloid. A consistent wake time anchors the circadian rhythm, and morning light reinforces it. The evidence is strong, the intervention is free, and it works for clients in their 30s and their 70s.

Move Practice: Strength Training

Wendy works with many of our clients in their late fifties and sixties. The trend she keeps seeing: clients who are doing aerobic exercise faithfully, often three or four days a week, and skipping strength training entirely.

“I’m flexible with many aspects of a health plan, but strength training is one area I strongly encourage people not to overlook. The research connecting muscle mass and brain health after 50 is incredibly compelling, and maintaining strength now can have a major impact on long-term health and quality of life.”

Strength training is another Essential Technique in our Move Practice. The reason it is essential, not optional: muscle is the primary site of glucose disposal in the body, the pathways linked to neurogenesis are responsive to resistance training, and sarcopenia is one of the strongest predictors of cognitive decline in older adults. The evidence supports two sessions a week, moderate intensity, sustained for at least six months. Bodyweight work and resistance bands are enough to start. The technique is essential because everyone past 30 is slowly losing muscle, and the cost of skipping it is too high.

Supplement Practice: Methylated B Vitamins

Another trend we keep seeing across our client base: people arriving with homocysteine in the 11 to 14 range, told by their primary care that it is fine. The gap between what is flagged at most labs and what is optimal for brain health is one of the cleanest examples of where our framework differs from standard care.

The optimal range for homocysteine is under 9 μmol/L. Most labs flag a result only above 15. The 9 to 14 range is where a meaningful number of clients are quietly carrying elevated risk that has been waved off. A methylated B-complex moves the marker for the majority of clients within three months, and the cognitive payoff is real.

The Essential Technique in our Eat Practice is targeted methylated B-complex supplementation. The reason this is essential for almost everyone has to do with the underlying biology. Homocysteine is cleared through methylation pathways that depend on the active forms of folate, B12, and B6. A significant portion of the population carries variants of the MTHFR gene that reduce how well the body converts standard folic acid into the active form.

 Methylated B-complexes deliver the active forms directly. For anyone over 40 thinking about long-term brain health, this is one of the highest-leverage interventions available.

What the pattern reveals

Across our coaches with different specialties and different client populations, the same Essential Techniques keep coming up. These are the techniques that consistently move the needle, regardless of who is doing them. What our coaches actually do day to day is build action plans that span the full technique library: prioritizing among the Essentials and layering in the context-dependent techniques that fit each client’s panel and life.

The Essentials are universal. The action plan is personal.

If you are thinking about long-term brain health, the Essential Techniques are the highest-leverage place to start. They are the techniques our clinical advisors backed because the evidence is strong and they work for almost everyone.

If you’d like a quick read on which Essential Techniques to prioritize based on what you are already doing, take the free Essential Scan. Open to anyone, whether you’re already a BetterBrain client or just starting.

If you’d like a deeper personalized action plan, BetterBrain coachingpairs you with a Brain Health Coach who builds the plan with you based on your biology and lifestyle.

May 12, 2026
7 mins

Grey Matters: Visceral fat, glycemic control, and your hippocampus

The research, called the Follow-Interventions-Trials (FIT) project, pulled participants from four earlier 18 to 24 month lifestyle randomized...

What the Study Found

The research, called the Follow-Interventions-Trials (FIT) project, pulled participants from four earlier 18 to 24 month lifestyle randomized trials. The average age at follow-up was 61. Each participant had abdominal MRI, brain MRI, and Montreal Cognitive Assessment (MoCA) testing 5 to 16 years after their original intervention.

Three findings stood out. Lower long-term visceral fat exposure, calculated across baseline, post-intervention, and follow-up, independently predicted higher cognitive scores. Visceral fat loss during the intervention period predicted higher brain volumes years later, independent of overall weight loss. And among the participants who had three full sets of scans over the years, lower long-term visceral fat was associated with a slower rate of brain atrophy.

The same patterns were not observed for subcutaneous fat, the kind that sits under the skin and shows up on a pinch test. Visceral fat, the deeper fat surrounding the organs, was the variable that mattered.

The proposed mechanism is glycemic. Visceral fat is metabolically active. It secretes inflammatory signals and contributes to insulin resistance. Both of these are increasingly understood as drivers of cognitive decline. When visceral fat goes down, glycemic control improves, and the brain appears to benefit downstream.

Why this changes how we think about midlife weight

Most people who decide to lose weight in their fifties do not distinguish between subcutaneous fat, visceral fat, and muscle. Many lose all three. Losing muscle in midlife is a problem on its own. Losing subcutaneous fat without losing visceral fat is largely cosmetic. Losing visceral fat appears to be the part that actually protects the brain.

This also reframes "skinny fat." A person can have a body mass index in the normal range and still carry significant visceral fat. The scale will not flag this. A waist measurement, a DEXA scan, or abdominal imaging will.

For anyone in their 40s, 50s, or 60s thinking about brain health, the practical question is no longer "should I lose weight." It is "what is my visceral fat doing, and what is actually moving it."

What you can do

Three things tend to move visceral fat without requiring dramatic restriction.

The first is reducing refined carbohydrates and added sugars. Visceral fat is more responsive to insulin signaling than subcutaneous fat. Lowering postprandial glucose spikes is associated with reduced visceral fat over time.

The second is consistent moderate-intensity movement, especially after meals. A 10 to 15 minute walk after eating blunts the post-meal glucose curve. Repeated over months, this contributes meaningfully to visceral fat reduction.

The third is strength training, which we covered last week. Muscle is the primary site of glucose disposal in the body. More muscle means better glycemic control, which means less visceral fat accumulation.

The biomarkers that respond, and the ones we look at first with members, are HbA1c (your average blood sugar over three months), fasting insulin, and the broader metabolic panel that looks at lipids and liver function. These shift before the scale shifts. They tell you whether the metabolic conditions that drive visceral fat are improving.

What you can do

The next time someone tells you to lose weight for your brain, the more useful version of that advice is to lose visceral fat for your brain. The number on the scale was always a poor proxy for what is happening inside the body. The new research makes that clearer.

If you are already a BetterBrain client, your most recent HbA1c, fasting insulin, and metabolic panel results are in your dashboard. Worth a fresh look in light of this.

If you have not yet started, these markers are part of the BetterBrain Essentials Panel we look at first.

Get immediate insights with a 3 minute assessment

Start now